Head of Research & Development, Medcann Pharma With more than 25 years in preclinical and clinical drug development, Lewis Cameron serves as the Head of Research & Development at Medcann Pharma. Lewis has worked with small and large companies in the biotechnology sector, central laboratories and CROs and has experience in all phases of drug development across many Therapeutic Areas including Oncology, CNS and Pain. As an accomplished senior executive, Lewis has a proven track record in delivering outstanding operational and commercial results in challenging and innovative market sectors. Prior to Medcann he was Global Head of Clinical Development at Covance, and prios to that as Chief Executive Officer at the biotech, Avillion.
Lewis earned his bachelor’s degree from Edinburgh University, a master’s degree in biotechnology from the University of Reading and his MBA from Instituto de Empresa in Madrid. He is based in Madrid, Spain.